GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Institutional Ownership

Exicure (STU:2H0A) Institutional Ownership : 0.90% (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Exicure Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Exicure's institutional ownership is 0.90%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Exicure's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Exicure's Float Percentage Of Total Shares Outstanding is 87.24%.


Exicure Institutional Ownership Historical Data

The historical data trend for Exicure's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exicure Institutional Ownership Chart

Exicure Historical Data

The historical data trend for Exicure can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.59 0.95 0.95 0.95 0.87 0.89 0.89 0.90 0.90 0.90

Exicure Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Exicure (STU:2H0A) Business Description

Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Exicure (STU:2H0A) Headlines

No Headlines